Teleflex (NYSE:TFX) Stock Price Passes Above 200-Day Moving Average – Time to Sell?

Teleflex Incorporated (NYSE:TFX) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $119.67 and traded as high as $131.64. Teleflex shares last traded at $129.5690, with a volume of 602,441 shares trading hands.

Analyst Ratings Changes

Several research firms have weighed in on TFX. Piper Sandler upgraded Teleflex from a “neutral” rating to an “overweight” rating and upped their price target for the stock from $140.00 to $160.00 in a research note on Monday, June 8th. Raymond James Financial reissued an “outperform” rating and issued a $150.00 target price on shares of Teleflex in a report on Friday, May 8th. Truist Financial restated a “hold” rating and set a $143.00 target price (up from $135.00) on shares of Teleflex in a research report on Monday, May 11th. Wall Street Zen raised shares of Teleflex from a “sell” rating to a “hold” rating in a research note on Saturday. Finally, Mizuho set a $140.00 price target on shares of Teleflex in a report on Friday, May 8th. Four analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $146.00.

Teleflex Price Performance

The firm has a market cap of $5.74 billion, a PE ratio of -5.68, a PEG ratio of 0.97 and a beta of 0.82. The firm has a fifty day simple moving average of $130.03 and a two-hundred day simple moving average of $119.67. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.03 and a current ratio of 2.55.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.21 by $0.18. The business had revenue of $548.30 million for the quarter, compared to the consensus estimate of $536.91 million. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The company’s revenue was up 32.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.44 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Equities analysts predict that Teleflex Incorporated will post 6.7 EPS for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th will be given a dividend of $0.34 per share. The ex-dividend date is Friday, May 22nd. This represents a $1.36 annualized dividend and a yield of 1.0%. Teleflex’s dividend payout ratio (DPR) is -5.96%.

Hedge Funds Weigh In On Teleflex

A number of institutional investors and hedge funds have recently made changes to their positions in TFX. Ruffer LLP purchased a new position in Teleflex during the fourth quarter worth $5,154,000. Waterfront Wealth Inc. purchased a new stake in shares of Teleflex in the fourth quarter valued at $2,050,000. Eos Management L.P. purchased a new stake in shares of Teleflex in the fourth quarter valued at $3,763,000. Capital International Investors bought a new stake in shares of Teleflex in the 3rd quarter worth about $44,851,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH lifted its holdings in shares of Teleflex by 227.5% in the 4th quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 27,822 shares of the medical technology company’s stock worth $3,395,000 after acquiring an additional 19,327 shares during the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.